Cowealth Medical Holding Co Ltd (4745) - Net Assets
Based on the latest financial reports, Cowealth Medical Holding Co Ltd (4745) has net assets worth NT$4.71 Billion TWD (≈ $148.39 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$6.65 Billion ≈ $209.52 Million USD) and total liabilities (NT$1.94 Billion ≈ $61.12 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 4745 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | NT$4.71 Billion |
| % of Total Assets | 70.83% |
| Annual Growth Rate | 17.65% |
| 5-Year Change | 51.38% |
| 10-Year Change | N/A |
| Growth Volatility | 27.9 |
Cowealth Medical Holding Co Ltd - Net Assets Trend (2017–2024)
This chart illustrates how Cowealth Medical Holding Co Ltd's net assets have evolved over time, based on quarterly financial data. Also explore how large is Cowealth Medical Holding Co Ltd's balance sheet for the complete picture of this company's asset base.
Annual Net Assets for Cowealth Medical Holding Co Ltd (2017–2024)
The table below shows the annual net assets of Cowealth Medical Holding Co Ltd from 2017 to 2024. For live valuation and market cap data, see market value of Cowealth Medical Holding Co Ltd.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | NT$5.19 Billion ≈ $163.65 Million |
+3.30% |
| 2023-12-31 | NT$5.03 Billion ≈ $158.42 Million |
-3.34% |
| 2022-12-31 | NT$5.20 Billion ≈ $163.89 Million |
+47.57% |
| 2021-12-31 | NT$3.53 Billion ≈ $111.06 Million |
+2.74% |
| 2020-12-31 | NT$3.43 Billion ≈ $108.10 Million |
+2.59% |
| 2019-12-31 | NT$3.34 Billion ≈ $105.38 Million |
+76.81% |
| 2018-12-31 | NT$1.89 Billion ≈ $59.60 Million |
+13.66% |
| 2017-12-31 | NT$1.66 Billion ≈ $52.44 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Cowealth Medical Holding Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 41.1% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | NT$411.76 Million | 14.71% |
| Other Components | NT$2.39 Billion | 85.29% |
| Total Equity | NT$2.80 Billion | 100.00% |
Cowealth Medical Holding Co Ltd Competitors by Market Cap
The table below lists competitors of Cowealth Medical Holding Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Ravad Ltd
TA:RAVD
|
$47.71 Million |
|
Bright Sheland International Co Ltd
TWO:4556
|
$47.71 Million |
|
Hilbert Group AB Series B
ST:HILB-B
|
$47.72 Million |
|
PT Indo Boga Sukses Tbk
JK:IBOS
|
$47.73 Million |
|
Texton Property Fund Ltd
JSE:TEX
|
$47.69 Million |
|
Ausquest Ltd
AU:AQD
|
$47.66 Million |
|
Nuveen New York Select Tax-Free Income Portfolio
NYSE:NXN
|
$47.65 Million |
|
Hong Yi Fiber Industry Co Ltd
TW:1452
|
$47.64 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Cowealth Medical Holding Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 2,718,884,000 to 2,798,820,000, a change of 79,936,000 (2.9%).
- Net income of 629,000 contributed positively to equity growth.
- Dividend payments of 30,980,000 reduced retained earnings.
- Other factors increased equity by 110,287,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | NT$629.00K | +0.02% |
| Dividends Paid | NT$30.98 Million | -1.11% |
| Other Changes | NT$110.29 Million | +3.94% |
| Total Change | NT$- | 2.94% |
Book Value vs Market Value Analysis
This analysis compares Cowealth Medical Holding Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.54x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 0.94x to 0.54x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | NT$20.81 | NT$19.55 | x |
| 2018-12-31 | NT$23.63 | NT$19.55 | x |
| 2019-12-31 | NT$31.57 | NT$19.55 | x |
| 2020-12-31 | NT$32.84 | NT$19.55 | x |
| 2021-12-31 | NT$33.13 | NT$19.55 | x |
| 2022-12-31 | NT$36.59 | NT$19.55 | x |
| 2023-12-31 | NT$35.09 | NT$19.55 | x |
| 2024-12-31 | NT$36.14 | NT$19.55 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Cowealth Medical Holding Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.02%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.02%
- • Asset Turnover: 0.60x
- • Equity Multiplier: 2.49x
- Recent ROE (0.02%) is below the historical average (6.65%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 10.43% | 5.72% | 0.84x | 2.18x | NT$7.14 Million |
| 2018 | 15.64% | 7.34% | 0.95x | 2.24x | NT$103.14 Million |
| 2019 | 11.44% | 6.00% | 0.86x | 2.21x | NT$35.27 Million |
| 2020 | 4.89% | 2.63% | 0.88x | 2.11x | NT$-130.12 Million |
| 2021 | 5.43% | 2.71% | 0.95x | 2.10x | NT$-117.32 Million |
| 2022 | 3.32% | 1.67% | 0.78x | 2.54x | NT$-189.42 Million |
| 2023 | 2.05% | 1.16% | 0.73x | 2.44x | NT$-216.18 Million |
| 2024 | 0.02% | 0.02% | 0.60x | 2.49x | NT$-279.25 Million |
Industry Comparison
This section compares Cowealth Medical Holding Co Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $1,580,385,400
- Average return on equity (ROE) among peers: 7.23%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Cowealth Medical Holding Co Ltd (4745) | NT$4.71 Billion | 10.43% | 0.41x | $47.70 Million |
| Hi-Clearance (1788) | $1.63 Billion | 15.45% | 0.61x | $190.76 Million |
| Radiant Innovation (3373) | $1.02 Billion | 2.81% | 0.09x | $25.35 Million |
| Wellell Inc (4106) | $1.31 Billion | 13.81% | 0.24x | $70.90 Million |
| Rossmax International Ltd (4121) | $1.34 Billion | 1.24% | 0.71x | $38.32 Million |
| United Orthopedic (4129) | $2.93 Billion | 3.48% | 0.91x | $298.97 Million |
| Dynamic Medical Technologies (4138) | $1.47 Billion | 7.66% | 0.52x | $70.45 Million |
| Ok Biotech Co Ltd (4155) | $2.40 Billion | 0.12% | 0.28x | $59.00 Million |
| Bioptik Technology (4161) | $717.83 Million | 6.76% | 1.11x | $44.28 Million |
| AViTA Corporation (4735) | $888.28 Million | 4.81% | 0.39x | $36.39 Million |
| TAIDOC TECHNOLOGY CORP (4736) | $2.11 Billion | 16.22% | 0.51x | $375.60 Million |
About Cowealth Medical Holding Co Ltd
Cowealth Medical Holding Co., Ltd., together with its subsidiaries, engages in trading of medical equipment, reagents, and spare parts in Taiwan, China, and Hong Kong. It operates in two segments, Sells Equipment, and Sells Reagents and Others. The company also offers acme empowerment program, including al-assisted clinical decision support system, platform of management analysis and decision mak… Read more